Literature DB >> 6608495

Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis.

F Fish, J L Cowell, C R Manclark.   

Abstract

Immunization of mice with a whole-cell pertussis vaccine or with the purified, detoxified lymphocytosis-promoting factor (LPF) of Bordetella pertussis resulted in an increased in vitro proliferative response to LPF in immune lymph node cells. The proliferative response was detected above the nonspecific mitogenic activity of LPF. That the proliferative response of the immune lymph node cells was a demonstration of a specific cell-mediated immunity to LPF was supported by the following: (i) the specificity of the response to the immunizing antigen; (ii) the ability of chemically modified, nonmitogenic LPF to induce proliferation in immune lymph node cells; and (iii) a dependence on T-cells for the demonstration of the proliferative response of immune cells to LPF. Immunization of mice with protective doses of detoxified LPF resulted in serum antibody and cell-mediated responses to LPF. Immunization of mice with protective doses of whole-cell pertussis vaccine resulted in a cell-mediated response but not a detectable antibody response to LPF. The LPF of B. pertussis is believed to play an important role in pathogenesis and immunity in pertussis, and the demonstration of a cell-mediated immune response to LPF suggests a possible role for cell-mediated immunity to LPF in protection from pertussis disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608495      PMCID: PMC263448          DOI: 10.1128/iai.44.1.1-6.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Protein reagent modification of cholera toxin: characterization of effects on antigenic, receptor-binding and toxic properties.

Authors:  I Lönnroth; J Holmgren
Journal:  J Gen Microbiol       Date:  1975-12

Review 2.  Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.

Authors:  M Pittman
Journal:  Rev Infect Dis       Date:  1979 May-Jun

Review 3.  The role of cell-mediated immunity in bacterial infections.

Authors:  H Hahn; S H Kaufmann
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

4.  The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice.

Authors:  F Fish; M Ziff
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

5.  The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes.

Authors:  J H Morse; A S Kong; J Lindenbaum; S I Morse
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

6.  Aerosol infection of mice with Bordetella pertussis.

Authors:  Y Sato; K Izumiya; H Sato; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

7.  Biological activities of crystalline pertussigen from Bordetella pertussis.

Authors:  J J Munoz; H Arai; R K Bergman; P L Sadowski
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

8.  Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.

Authors:  J J Munoz; H Arai; R L Cole
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

9.  The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes: II. Nature of the responding cells.

Authors:  A S Kong; S I Morse
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.

Authors:  J T Frbes; Y Nakaw; R T Smith
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  6 in total

1.  Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis.

Authors:  J W Petersen; P H Ibsen; K Hasløv; I Heron
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.

Authors:  L Nencioni; M Pizza; M Bugnoli; T De Magistris; A Di Tommaso; F Giovannoni; R Manetti; I Marsili; G Matteucci; D Nucci
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.

Authors:  A Kimura; K T Mountzouros; P A Schad; W Cieplak; J L Cowell
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  Immune suppression and induction of gamma interferon by pertussis toxin.

Authors:  F R Vogel; T W Klein; W E Stewart; T Igarashi; H Friedman
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

5.  Resistance to adenovirus infection after administration of Bordetella pertussis vaccine in mice.

Authors:  A L Winters; D W Baggett; W R Benjamin; H K Brown; T W Klein
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

6.  Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.

Authors:  A Kimura; K T Mountzouros; D A Relman; S Falkow; J L Cowell
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.